Differentially expressed genes (postinfusion vs infusion)
| Gene . | Description . | FC . | P . |
|---|---|---|---|
| CYBB | Cytochrome b-245, β polypeptide | 27.08 | .03 |
| CSF3R | Colony stimulating factor 3 receptor (granulocyte) | 21.76 | .02 |
| TNFAIP3 | Tumor necrosis factor, α-induced protein 3 | 19.03 | .004 |
| CD14 | CD14 molecule | 18.81 | .02 |
| LILRA2 | Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 | 18.27 | .02 |
| CD36 | CD36 molecule (thrombospondin receptor) | 14.10 | .04 |
| FCGR2C | Fc fragment of IgG, low affinity IIc, receptor for (CD32) | 12.36 | .02 |
| CR1 | Complement component (3b/4b) receptor 1 | 11.65 | .01 |
| CX3CR1 | Chemokine (C-X3-C motif) receptor 1 | 11.29 | .009 |
| FCGR3A | Fc fragment of IgG, low affinity IIIa, receptor (CD16a) | 10.30 | .002 |
| IL7R | Interleukin 7 receptor | 9.31 (12.80) | .02 |
| TGFBI | Transforming growth factor, β-induced, 68kDa | 9.03 | .03 |
| TLR8 | Toll-like receptor 8 | 7.73 | .02 |
| NFKBIA | Nuclear factor of κ light polypeptide gene enhancer in B-cells inhibitor, α | 7.57 | .006 |
| KLRD1 | Killer cell lectin-like receptor subfamily D, member 1 | 7.35 | .001 |
| LILRA3 | Leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 | 7.17 | .007 |
| FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 6.99 | .03 |
| IL1RN | Interleukin 1 receptor antagonist | 6.94 | .03 |
| LILRB2 | Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 | 6.68 | .02 |
| PTGS2 | Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 6.32 (14.02) | .03 |
| PPBP | Pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 6.26 | .04 |
| LTBR | Lymphotoxin B receptor | 6.14 | .04 |
| SELL | Selectin L | 6.10 (11.62) | .02 |
| IFIT2 | Interferon-induced protein with tetratricopeptide repeats 2 | 5.61 | .003 |
| LILRB4 | Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4 | 5.57 | .03 |
| BST1 | Bone marrow stromal cell antigen 1 | 5.49 | .02 |
| TCF7 | Transcription factor 7 (T-cell specific, HMG-box) | 5.41 | .01 |
| FCGRT | Fc fragment of IgG, receptor, transporter, α” | 5.38 | .02 |
| MSR1 | Macrophage scavenger receptor 1 | 5.17 | .0009 |
| CXCR4 | Chemokine (C-X-C motif) receptor 4 | 5.09 | .003 |
| LILRA1 | Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 | 5.08 | .01 |
| TNFSF13B | Tumor necrosis factor (ligand) superfamily, member 13b | 5.00 | .008 |
| CD1D | CD1d molecule | 4.99 | .003 |
| LITAF | Lipopolysaccharide-induced TNF factor | 4.98 | .001 |
| KIR3DS1 | Killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1 | 4.98 | .03 |
| FCER1A | Fc fragment of IgE, high affinity I, receptor for; α polypeptide | 4.87 | .01 |
| KIR2DL2 | Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2 | 4.79 | .03 |
| CFD | Complement factor D (adipsin) | 4.74 | .004 |
| TLR2 | Toll-like receptor 2 | 4.68 | .03 |
| SOCS3 | Suppressor of cytokine signaling 3 | 4.61 | .01 |
| LILRB1 | Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | 4.59 | .001 |
| CLEC4E | C-type lectin domain family 4, member E | 4.52 | .02 |
| NCR1 | Natural cytotoxicity triggering receptor 1 | 4.35 | .002 |
| BTK | Bruton agammaglobulinemia tyrosine kinase | 4.18 | <.05 |
| PDCD1 | Programmed cell death 1 | 4.06 | .009 |
| SERPING1 | Serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 | 3.98 | .002 |
| CLEC4A | C-type lectin domain family 4, member A | 3.94 | .02 |
| ITGA6 | Integrin, α 6 | 3.92 | .001 |
| LILRB3 | Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 | 3.84 | .005 |
| NOS2 | Nitric oxide synthase 2, inducible | 3.52 | .01 |
| IL6R | Interleukin 6 receptor | 3.50 | .03 |
| CXCR2 | Chemokine (C-X-C motif) receptor 2 | 3.40 | .01 |
| FYN | FYN oncogene related to SRC, FGR, YES | 3.31 | .00006 |
| PTAFR | Platelet-activating factor receptor | 3.26 | .01 |
| IRAK3 | Interleukin-1 receptor-associated kinase 3 | 3.25 | .02 |
| FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 3.25 | .0003 |
| CFP | Complement factor properdin | 3.23 | .01 |
| TAGAP | T-cell activation RhoGTPase activating protein | 3.05 | .0009 |
| IL18 | Interleukin 18 (interferon-γ-inducing factor) | 3.03 | .003 |
| CSF1R | Colony stimulating factor 1 receptor | 3.00 | .01 |
| IL10 | Interleukin 10 | 2.99 (20.78) | .02 |
| RARRES3 | Retinoic acid receptor responder (tazarotene induced) 3 | 2.99 | .001 |
| IL19 | Interleukin 19 | 2.97 | .009 |
| ITGAM | Integrin, α M (complement component 3 receptor 3 subunit)” | 2.94 | .01 |
| TLR3 | Toll-like receptor 3 | 2.94 | .0009 |
| TRAF6 | TNF receptor-associated factor 6, E3 ubiquitin protein ligase” | 2.90 | .002 |
| C2 | Complement component 2 | 2.89 | .0003 |
| PTGER4 | Prostaglandin E receptor 4 (subtype EP4) | 2.89 | .001 |
| CCL11 | Chemokine (C-C motif) ligand 11 | 2.83 | .01 |
| IL23A | Interleukin 23, α subunit p19 | 2.83 | .01 |
| IL12A | Interleukin 12A (natural killer cell stimulatory factor 1, p35) | 2.80 | .003 |
| C7 | Complement component 7 | 2.77 | .02 |
| IL15 | Interleukin 15 | 2.71 (3.73) | .02 |
| SIGIRR | Single immunoglobulin and toll-interleukin 1 receptor (TIR) domain | 2.67 | .0003 |
| LILRA6 | Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 | 2.67 | .01 |
| C1S | Complement component 1, s subcomponent | 2.66 | .01 |
| MASP2 | Mannan-binding lectin serine peptidase 2 | 2.65 | .006 |
| CEBPB | CCAAT/enhancer binding protein (C/EBP), β” | 2.64 | .03 |
| PRDM1 | PR domain containing 1, with ZNF domain | 2.64 | .0009 |
| RAG2 | Recombination activating gene 2 | 2.58 | <.05 |
| TLR1 | Toll-like receptor 1 | 2.58 | .001 |
| FKBP5 | FK506 binding protein 5 | 2.52 | .01 |
| TGFB1 | Transforming growth factor, β 1 | 2.49 (2.83) | .002 |
| NFKBIZ | Nuclear factor of κ light polypeptide gene enhancer in B-cells inhibitor, ζ | 2.48 | .004 |
| IRF1 | Interferon regulatory factor 1 | 2.48 | .00002 |
| DEFB1 | Defensin, β 1” | 2.46 | .003 |
| CLU | Clusterin | 2.45 | .02 |
| FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) | 2.44 | .003 |
| ITGB1 | Integrin, β 1 (fibronectin receptor, β polypeptide, antigen CD29 includes MDF2, MSK12) | 2.44 | .01 |
| IRF7 | Interferon regulatory factor 7 | 2.43 | .0005 |
| MARCO | Macrophage receptor with collagenous structure | 2.41 | .01 |
| IRGM | Immunity-related GTPase family, M | 2.38 | .02 |
| IL6ST | Interleukin 6 signal transducer (gp130, oncostatin M receptor) | 2.37 | .002 |
| CASP8 | Caspase 8, apoptosis-related cysteine peptidase | 2.36 | .001 |
| ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | 2.35 | .0002 |
| IL1RL2 | Interleukin 1 receptor-like 2 | 2.33 | .04 |
| LTB4R | Leukotriene B4 receptor | 2.33 | .003 |
| LTF | Lactotransferrin | 2.32 | .006 |
| MX1 | Myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 | 2.32 | .03 |
| ITGA2B | Integrin, α 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 2.29 | .02 |
| GNLY | Granulysin | 2.29 | .03 |
| IFIH1 | Interferon induced with helicase C domain 1 | 2.29 | .0006 |
| CXCL10 | Chemokine (C-X-C motif) ligand 10 | 2.28 | .04 |
| LTB4R2 | Leukotriene B4 receptor 2 | 2.26 | .0007 |
| PDCD2 | Programmed cell death 2 | 2.26 | .002 |
| CD209 | CD209 molecule | 2.24 | .004 |
| XCR1 | Chemokine (C motif) receptor 1 | 2.23 | .03 |
| TLR5 | Toll-like receptor 5 | 2.22 | .0005 |
| MBP | Myelin basic protein | 2.22 | .007 |
| ITGA5 | Integrin, α 5 (fibronectin receptor, α polypeptide) | 2.21 | .0006 |
| IKZF3 | IKAROS family zinc finger 3 (Aiolos) | 2.21 | .00008 |
| C1QB | Complement component 1, q subcomponent, B chain | 2.21 | .002 |
| C8G | Complement component 8, γ polypeptide | 2.18 | .005 |
| JAK1 | Janus kinase 1 | 2.18 | .0001 |
| TBX21 | T-box 21 | 2.18 (2.03) | .02 |
| STAT5B | Signal transducer and activator of transcription 5B | 2.15 | .004 |
| ATG16L1 | Autophagy related 16-like 1 (S. cerevisiae) | 2.13 | .002 |
| C4B | Complement component 4B (Chido blood group) | 2.12 | .008 |
| IL1R2 | Interleukin 1 receptor, type II | 2.12 | .04 |
| IRF8 | Interferon regulatory factor 8 | 2.09 | <.05 |
| HLA-C | Major histocompatibility complex, class I, C | 2.09 | .0002 |
| PLA2G2E | Phospholipase A2, group IIE | 2.09 | <.05 |
| ZAP70 | ζ-chain (TCR) associated protein kinase 70kDa | 2.09 | .0002 |
| ATM | Ataxia telangiectasia mutated | 2.08 | .01 |
| PTPRC | Protein tyrosine phosphatase, receptor type, C | 2.08 | .0006 |
| BCL6 | B-cell CLL/lymphoma 6 | 2.07 | .04 |
| CD44 | CD44 molecule (Indian blood group) | 2.04 | .01 |
| RAG1 | Recombination activating gene 1 | 2.03 | .04 |
| PML | Promyelocytic leukemia | 2.02 | .006 |
| CASP1 | Caspase 1, apoptosis-related cysteine peptidase | 2.01 | .0006 |
| MYD88 | Myeloid differentiation primary response 88 | 2.01 | .0001 |
| IL21R | Interleukin 21 receptor | 2.01 | <.05 |
| BCL2 | B-cell CLL/lymphoma 2 | −2.03 | .004 |
| CEACAM1 | Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | −2.06 | .02 |
| CCR5 | Chemokine (C-C motif) receptor 5 | −2.09 | .003 |
| SOCS1 | Suppressor of cytokine signaling 1 | −2.29 | .002 |
| HLA-DRB1 | Major histocompatibility complex, class II, DR β 1 | −2.38 | .01 |
| IRF4 | Interferon regulatory factor 4 | −2.49 | .0005 |
| GZMA | Granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) | −2.55 | .01 |
| CCR2 | Chemokine (C-C motif) receptor 2 | −2.60 | .0002 |
| CSF1 | Colony stimulating factor 1 (macrophage) | −2.84 (−2.26) | .0002 |
| DPP4 | Dipeptidyl-peptidase 4 | −2.97 | .0002 |
| CCL3 | Chemokine (C-C motif) ligand 3 | −3.10 | .03 |
| CSF2RB | Colony stimulating factor 2 receptor, β, low-affinity (granulocyte-macrophage) | −3.24 | .02 |
| CXCR6 | Chemokine (C-X-C motif) receptor 6 | −3.41 | .01 |
| GPI | Glucose-6-phosphate isomerase | −3.72 | .008 |
| CD40LG | CD40 ligand | −3.87 (−3.83) | .005 |
| CSF2 | Colony stimulating factor 2 (granulocyte-macrophage) | −4.66 (−55.17) | .0002 |
| CCR8 | Chemokine (C-C motif) receptor 8 | −4.67 | .02 |
| FOXP3 | Forkhead box P3 | −4.82 (−4.88) | .02 |
| HLA-DQA1 | Major histocompatibility complex, class II, DQ α 1 | −4.95 | .03 |
| LTA | Lymphotoxin α | −5.34 (−5.49) | .0002 |
| IL2RA | Interleukin 2 receptor, α | −7.40 (−5.18) | .009 |
| CISH | Cytokine inducible SH2-containing protein | −8.31 | .00002 |
| TNFRSF8 | Tumor necrosis factor receptor superfamily, member 8 | −11.14 (−10.32) | .007 |
| IL13 | Interleukin 13 | −11.44 (−61.60) | .02 |
| Gene . | Description . | FC . | P . |
|---|---|---|---|
| CYBB | Cytochrome b-245, β polypeptide | 27.08 | .03 |
| CSF3R | Colony stimulating factor 3 receptor (granulocyte) | 21.76 | .02 |
| TNFAIP3 | Tumor necrosis factor, α-induced protein 3 | 19.03 | .004 |
| CD14 | CD14 molecule | 18.81 | .02 |
| LILRA2 | Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 | 18.27 | .02 |
| CD36 | CD36 molecule (thrombospondin receptor) | 14.10 | .04 |
| FCGR2C | Fc fragment of IgG, low affinity IIc, receptor for (CD32) | 12.36 | .02 |
| CR1 | Complement component (3b/4b) receptor 1 | 11.65 | .01 |
| CX3CR1 | Chemokine (C-X3-C motif) receptor 1 | 11.29 | .009 |
| FCGR3A | Fc fragment of IgG, low affinity IIIa, receptor (CD16a) | 10.30 | .002 |
| IL7R | Interleukin 7 receptor | 9.31 (12.80) | .02 |
| TGFBI | Transforming growth factor, β-induced, 68kDa | 9.03 | .03 |
| TLR8 | Toll-like receptor 8 | 7.73 | .02 |
| NFKBIA | Nuclear factor of κ light polypeptide gene enhancer in B-cells inhibitor, α | 7.57 | .006 |
| KLRD1 | Killer cell lectin-like receptor subfamily D, member 1 | 7.35 | .001 |
| LILRA3 | Leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 | 7.17 | .007 |
| FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 6.99 | .03 |
| IL1RN | Interleukin 1 receptor antagonist | 6.94 | .03 |
| LILRB2 | Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 | 6.68 | .02 |
| PTGS2 | Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 6.32 (14.02) | .03 |
| PPBP | Pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 6.26 | .04 |
| LTBR | Lymphotoxin B receptor | 6.14 | .04 |
| SELL | Selectin L | 6.10 (11.62) | .02 |
| IFIT2 | Interferon-induced protein with tetratricopeptide repeats 2 | 5.61 | .003 |
| LILRB4 | Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4 | 5.57 | .03 |
| BST1 | Bone marrow stromal cell antigen 1 | 5.49 | .02 |
| TCF7 | Transcription factor 7 (T-cell specific, HMG-box) | 5.41 | .01 |
| FCGRT | Fc fragment of IgG, receptor, transporter, α” | 5.38 | .02 |
| MSR1 | Macrophage scavenger receptor 1 | 5.17 | .0009 |
| CXCR4 | Chemokine (C-X-C motif) receptor 4 | 5.09 | .003 |
| LILRA1 | Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 | 5.08 | .01 |
| TNFSF13B | Tumor necrosis factor (ligand) superfamily, member 13b | 5.00 | .008 |
| CD1D | CD1d molecule | 4.99 | .003 |
| LITAF | Lipopolysaccharide-induced TNF factor | 4.98 | .001 |
| KIR3DS1 | Killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1 | 4.98 | .03 |
| FCER1A | Fc fragment of IgE, high affinity I, receptor for; α polypeptide | 4.87 | .01 |
| KIR2DL2 | Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2 | 4.79 | .03 |
| CFD | Complement factor D (adipsin) | 4.74 | .004 |
| TLR2 | Toll-like receptor 2 | 4.68 | .03 |
| SOCS3 | Suppressor of cytokine signaling 3 | 4.61 | .01 |
| LILRB1 | Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | 4.59 | .001 |
| CLEC4E | C-type lectin domain family 4, member E | 4.52 | .02 |
| NCR1 | Natural cytotoxicity triggering receptor 1 | 4.35 | .002 |
| BTK | Bruton agammaglobulinemia tyrosine kinase | 4.18 | <.05 |
| PDCD1 | Programmed cell death 1 | 4.06 | .009 |
| SERPING1 | Serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 | 3.98 | .002 |
| CLEC4A | C-type lectin domain family 4, member A | 3.94 | .02 |
| ITGA6 | Integrin, α 6 | 3.92 | .001 |
| LILRB3 | Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 | 3.84 | .005 |
| NOS2 | Nitric oxide synthase 2, inducible | 3.52 | .01 |
| IL6R | Interleukin 6 receptor | 3.50 | .03 |
| CXCR2 | Chemokine (C-X-C motif) receptor 2 | 3.40 | .01 |
| FYN | FYN oncogene related to SRC, FGR, YES | 3.31 | .00006 |
| PTAFR | Platelet-activating factor receptor | 3.26 | .01 |
| IRAK3 | Interleukin-1 receptor-associated kinase 3 | 3.25 | .02 |
| FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 3.25 | .0003 |
| CFP | Complement factor properdin | 3.23 | .01 |
| TAGAP | T-cell activation RhoGTPase activating protein | 3.05 | .0009 |
| IL18 | Interleukin 18 (interferon-γ-inducing factor) | 3.03 | .003 |
| CSF1R | Colony stimulating factor 1 receptor | 3.00 | .01 |
| IL10 | Interleukin 10 | 2.99 (20.78) | .02 |
| RARRES3 | Retinoic acid receptor responder (tazarotene induced) 3 | 2.99 | .001 |
| IL19 | Interleukin 19 | 2.97 | .009 |
| ITGAM | Integrin, α M (complement component 3 receptor 3 subunit)” | 2.94 | .01 |
| TLR3 | Toll-like receptor 3 | 2.94 | .0009 |
| TRAF6 | TNF receptor-associated factor 6, E3 ubiquitin protein ligase” | 2.90 | .002 |
| C2 | Complement component 2 | 2.89 | .0003 |
| PTGER4 | Prostaglandin E receptor 4 (subtype EP4) | 2.89 | .001 |
| CCL11 | Chemokine (C-C motif) ligand 11 | 2.83 | .01 |
| IL23A | Interleukin 23, α subunit p19 | 2.83 | .01 |
| IL12A | Interleukin 12A (natural killer cell stimulatory factor 1, p35) | 2.80 | .003 |
| C7 | Complement component 7 | 2.77 | .02 |
| IL15 | Interleukin 15 | 2.71 (3.73) | .02 |
| SIGIRR | Single immunoglobulin and toll-interleukin 1 receptor (TIR) domain | 2.67 | .0003 |
| LILRA6 | Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 | 2.67 | .01 |
| C1S | Complement component 1, s subcomponent | 2.66 | .01 |
| MASP2 | Mannan-binding lectin serine peptidase 2 | 2.65 | .006 |
| CEBPB | CCAAT/enhancer binding protein (C/EBP), β” | 2.64 | .03 |
| PRDM1 | PR domain containing 1, with ZNF domain | 2.64 | .0009 |
| RAG2 | Recombination activating gene 2 | 2.58 | <.05 |
| TLR1 | Toll-like receptor 1 | 2.58 | .001 |
| FKBP5 | FK506 binding protein 5 | 2.52 | .01 |
| TGFB1 | Transforming growth factor, β 1 | 2.49 (2.83) | .002 |
| NFKBIZ | Nuclear factor of κ light polypeptide gene enhancer in B-cells inhibitor, ζ | 2.48 | .004 |
| IRF1 | Interferon regulatory factor 1 | 2.48 | .00002 |
| DEFB1 | Defensin, β 1” | 2.46 | .003 |
| CLU | Clusterin | 2.45 | .02 |
| FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) | 2.44 | .003 |
| ITGB1 | Integrin, β 1 (fibronectin receptor, β polypeptide, antigen CD29 includes MDF2, MSK12) | 2.44 | .01 |
| IRF7 | Interferon regulatory factor 7 | 2.43 | .0005 |
| MARCO | Macrophage receptor with collagenous structure | 2.41 | .01 |
| IRGM | Immunity-related GTPase family, M | 2.38 | .02 |
| IL6ST | Interleukin 6 signal transducer (gp130, oncostatin M receptor) | 2.37 | .002 |
| CASP8 | Caspase 8, apoptosis-related cysteine peptidase | 2.36 | .001 |
| ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | 2.35 | .0002 |
| IL1RL2 | Interleukin 1 receptor-like 2 | 2.33 | .04 |
| LTB4R | Leukotriene B4 receptor | 2.33 | .003 |
| LTF | Lactotransferrin | 2.32 | .006 |
| MX1 | Myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 | 2.32 | .03 |
| ITGA2B | Integrin, α 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 2.29 | .02 |
| GNLY | Granulysin | 2.29 | .03 |
| IFIH1 | Interferon induced with helicase C domain 1 | 2.29 | .0006 |
| CXCL10 | Chemokine (C-X-C motif) ligand 10 | 2.28 | .04 |
| LTB4R2 | Leukotriene B4 receptor 2 | 2.26 | .0007 |
| PDCD2 | Programmed cell death 2 | 2.26 | .002 |
| CD209 | CD209 molecule | 2.24 | .004 |
| XCR1 | Chemokine (C motif) receptor 1 | 2.23 | .03 |
| TLR5 | Toll-like receptor 5 | 2.22 | .0005 |
| MBP | Myelin basic protein | 2.22 | .007 |
| ITGA5 | Integrin, α 5 (fibronectin receptor, α polypeptide) | 2.21 | .0006 |
| IKZF3 | IKAROS family zinc finger 3 (Aiolos) | 2.21 | .00008 |
| C1QB | Complement component 1, q subcomponent, B chain | 2.21 | .002 |
| C8G | Complement component 8, γ polypeptide | 2.18 | .005 |
| JAK1 | Janus kinase 1 | 2.18 | .0001 |
| TBX21 | T-box 21 | 2.18 (2.03) | .02 |
| STAT5B | Signal transducer and activator of transcription 5B | 2.15 | .004 |
| ATG16L1 | Autophagy related 16-like 1 (S. cerevisiae) | 2.13 | .002 |
| C4B | Complement component 4B (Chido blood group) | 2.12 | .008 |
| IL1R2 | Interleukin 1 receptor, type II | 2.12 | .04 |
| IRF8 | Interferon regulatory factor 8 | 2.09 | <.05 |
| HLA-C | Major histocompatibility complex, class I, C | 2.09 | .0002 |
| PLA2G2E | Phospholipase A2, group IIE | 2.09 | <.05 |
| ZAP70 | ζ-chain (TCR) associated protein kinase 70kDa | 2.09 | .0002 |
| ATM | Ataxia telangiectasia mutated | 2.08 | .01 |
| PTPRC | Protein tyrosine phosphatase, receptor type, C | 2.08 | .0006 |
| BCL6 | B-cell CLL/lymphoma 6 | 2.07 | .04 |
| CD44 | CD44 molecule (Indian blood group) | 2.04 | .01 |
| RAG1 | Recombination activating gene 1 | 2.03 | .04 |
| PML | Promyelocytic leukemia | 2.02 | .006 |
| CASP1 | Caspase 1, apoptosis-related cysteine peptidase | 2.01 | .0006 |
| MYD88 | Myeloid differentiation primary response 88 | 2.01 | .0001 |
| IL21R | Interleukin 21 receptor | 2.01 | <.05 |
| BCL2 | B-cell CLL/lymphoma 2 | −2.03 | .004 |
| CEACAM1 | Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | −2.06 | .02 |
| CCR5 | Chemokine (C-C motif) receptor 5 | −2.09 | .003 |
| SOCS1 | Suppressor of cytokine signaling 1 | −2.29 | .002 |
| HLA-DRB1 | Major histocompatibility complex, class II, DR β 1 | −2.38 | .01 |
| IRF4 | Interferon regulatory factor 4 | −2.49 | .0005 |
| GZMA | Granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) | −2.55 | .01 |
| CCR2 | Chemokine (C-C motif) receptor 2 | −2.60 | .0002 |
| CSF1 | Colony stimulating factor 1 (macrophage) | −2.84 (−2.26) | .0002 |
| DPP4 | Dipeptidyl-peptidase 4 | −2.97 | .0002 |
| CCL3 | Chemokine (C-C motif) ligand 3 | −3.10 | .03 |
| CSF2RB | Colony stimulating factor 2 receptor, β, low-affinity (granulocyte-macrophage) | −3.24 | .02 |
| CXCR6 | Chemokine (C-X-C motif) receptor 6 | −3.41 | .01 |
| GPI | Glucose-6-phosphate isomerase | −3.72 | .008 |
| CD40LG | CD40 ligand | −3.87 (−3.83) | .005 |
| CSF2 | Colony stimulating factor 2 (granulocyte-macrophage) | −4.66 (−55.17) | .0002 |
| CCR8 | Chemokine (C-C motif) receptor 8 | −4.67 | .02 |
| FOXP3 | Forkhead box P3 | −4.82 (−4.88) | .02 |
| HLA-DQA1 | Major histocompatibility complex, class II, DQ α 1 | −4.95 | .03 |
| LTA | Lymphotoxin α | −5.34 (−5.49) | .0002 |
| IL2RA | Interleukin 2 receptor, α | −7.40 (−5.18) | .009 |
| CISH | Cytokine inducible SH2-containing protein | −8.31 | .00002 |
| TNFRSF8 | Tumor necrosis factor receptor superfamily, member 8 | −11.14 (−10.32) | .007 |
| IL13 | Interleukin 13 | −11.44 (−61.60) | .02 |
NanoString data. RT-PCR data in parentheses.